title: Management of Brugada Syndrome 2016: Should All High Risk Patients Receive an ICD? Alternatives to Implantable Cardiac Defibrillator Therapy for Brugada Syndrome.
authors.affiliation: From the Department of Cardiology, Tel-Aviv Sourasky Medical Center, Sackler Faculty of Medicine, Tel-Aviv University, Israel. bblhass@tasmc.health.gov.il.
authors.forename: Bernard
authors.initials: B
authors.lastname: Belhassen
mesh_terms: D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use*; D053840:Brugada Syndrome / Q000145:classification / Q000503:physiopathology / Q000628:therapy*; D017115:Catheter Ablation / Q000379:methods*; D016757:Death, Sudden, Cardiac / Q000517:prevention & control*; D017147:Defibrillators, Implantable; D004562:Electrocardiography; D006801:Humans; D018579:Patient Selection; D010641:Phenotype; D011802:Quinidine / Q000627:therapeutic use*; D018570:Risk Assessment
chemical_list: D000889:Anti-Arrhythmia Agents; D011802:Quinidine
keywords: Brugada syndrome; ablation; drug therapy; electric stimulation; electrophysiology test; quinidine